Major pharmaceutical company Moderna announced Monday stage three clinical trials of a Wuhan coronavirus vaccine have been 94.5 percent effective.

“This is a pivotal moment in the development of our COVID-19 vaccine candidate. Since early January, we have chased this virus with the intent to protect as many people around the world as possible.…

This news comes via ChinaPulse.com, which delivers news, data, analysis, and insights on Chinese business, travel, finance, health, military, investment, and technology.